-
-
-
-
-
-
-
Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Vaxcyte (PCVX)
-
-
-
-
-
-
-
Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
-
-
-
-
-
-
-
Vaxcyte, Inc. (PCVX) Misses Q4 EPS by 251c
-
-
-
-
-
-
-
Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Vaxcyte to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022
-
-
-
-
-
-
-
Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
-
1,197,307 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

